Skip to main content

Medifast Inc (MED)

Household and Personal Products Consumer Staples
Stock AI

Financial Metrics

Price to Earnings-5.06x
Revenue Growth (1Y)-34.03%
Debt to Equity0.026x

Strengths

Stock Chart

Valuation

Medifast Inc is overvalued

News

All
Press Releases
News
Filings
Medifast Announces Second Quarter 2026 Financial Results
August 03, 2026Medifast Announces Second Quarter 2026 Financial Results
10-Q Quarterly Report for 2026 Q2
August 03, 202610-Q Quarterly Report for 2026 Q2
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026
July 20, 2026Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026
Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System
July 17, 2026Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer
May 26, 2026Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer
Medifast Announces First Quarter 2026 Financial Results
May 04, 2026Medifast Announces First Quarter 2026 Financial Results
10-Q Quarterly Report for 2026 Q1
May 04, 202610-Q Quarterly Report for 2026 Q1
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026
April 20, 2026Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026
Medifast Announces Cooperation Agreement with Steamboat Capital
March 20, 2026Medifast Announces Cooperation Agreement with Steamboat Capital
Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
February 20, 2026Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
February 17, 2026Medifast Announces Fourth Quarter and Full Year 2025 Financial Results
10-K Annual Report for 2025 FY
February 17, 202610-K Annual Report for 2025 FY
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025
February 03, 2026Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025
People Magazine Spotlights Tiffany Howard’s Metabolic Health Journey with OPTAVIA®
January 16, 2026People Magazine Spotlights Tiffany Howard’s Metabolic Health Journey with OPTAVIA®
OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity
January 15, 2026OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity
Medifast Announces Planned Leadership Transition
January 05, 2026Medifast Announces Planned Leadership Transition
OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
December 09, 2025OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
November 13, 2025Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
Medifast Announces Third Quarter 2025 Financial Results
November 03, 2025Medifast Announces Third Quarter 2025 Financial Results
10-Q Quarterly Report for 2025 Q3
November 03, 202510-Q Quarterly Report for 2025 Q3
Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™
October 27, 2025Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025
October 21, 2025Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025
Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes
September 15, 2025Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes
Medifast Announces Second Quarter 2025 Financial Results
August 04, 2025Medifast Announces Second Quarter 2025 Financial Results
10-Q Quarterly Report for 2025 Q2
August 04, 202510-Q Quarterly Report for 2025 Q2
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025
July 21, 2025Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025
Medifast Announces First Quarter 2025 Financial Results
April 28, 2025Medifast Announces First Quarter 2025 Financial Results
10-Q Quarterly Report for 2025 Q1
April 28, 202510-Q Quarterly Report for 2025 Q1
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025
April 14, 2025Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025
Medifast Announces Fourth Quarter and Full Year 2024 Financial Results
February 18, 2025Medifast Announces Fourth Quarter and Full Year 2024 Financial Results
10-K Annual Report for 2024 FY
February 18, 202510-K Annual Report for 2024 FY
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
February 04, 2025Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off
January 07, 2025Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off
Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications
December 05, 2024Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications
Medifast Announces Third Quarter 2024 Financial Results
November 04, 2024Medifast Announces Third Quarter 2024 Financial Results
10-Q Quarterly Report for 2024 Q3
November 04, 202410-Q Quarterly Report for 2024 Q3
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024
October 21, 2024Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024
Medifast Announces Second Quarter 2024 Financial Results
August 05, 2024Medifast Announces Second Quarter 2024 Financial Results
10-Q Quarterly Report for 2024 Q2
August 05, 202410-Q Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q1
April 29, 202410-Q Quarterly Report for 2024 Q1
10-K Annual Report for 2023 FY
February 20, 202410-K Annual Report for 2023 FY
10-Q Quarterly Report for 2023 Q3
November 06, 202310-Q Quarterly Report for 2023 Q3
10-Q Quarterly Report for 2023 Q2
August 07, 202310-Q Quarterly Report for 2023 Q2
10-Q Quarterly Report for 2023 Q1
May 01, 202310-Q Quarterly Report for 2023 Q1
10-K Annual Report for 2022 FY
February 21, 202310-K Annual Report for 2022 FY
10-Q Quarterly Report for 2022 Q3
November 03, 202210-Q Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q2
August 03, 202210-Q Quarterly Report for 2022 Q2
10-Q Quarterly Report for 2022 Q1
May 02, 202210-Q Quarterly Report for 2022 Q1
10-K Annual Report for 2021 FY
February 23, 202210-K Annual Report for 2021 FY
10-Q Quarterly Report for 2021 Q3
November 04, 202110-Q Quarterly Report for 2021 Q3

A. Company Overview

Medifast Inc., a prominent health and wellness entity, is renowned for its lifestyle solution, OPTAVIA®, which is habit-based and coach-guided. Established over 40 years ago by physicians, Medifast has evolved to become a leader in the U.S. weight management market. The company has recently expanded its offerings to include medically supported weight loss and sports nutrition, demonstrating a commitment to adapting to the dynamic needs of its customer base and the health industry.

Under current leadership, Medifast has transformed into a well-capitalized business with OPTAVIA evolving into a billion-dollar brand. The company boasts a robust network of over 41,100 active earning independent Coaches, influencing the lives of more than 3 million customers. Recent accolades include recognition from Financial Times as one of The Americas' Fastest Growing Companies in 2023 and inclusion in Forbes' list of America's Best Mid-Sized Companies in 2022.

Mission and Vision

Medifast’s mission, encapsulated in the slogan “Lifelong Transformation, One Healthy Habit at a Time®,” emphasizes the organization’s commitment to facilitating long-term health transformations for its community. By providing comprehensive health and nutritional solutions, the Company aims to address the evolving needs of its customer base effectively.

Business Model

The Medifast business model leverages a direct-selling approach, capitalizing on a network of independent OPTAVIA Coaches who provide personalized support to customers. This model is customer-centric, focusing on making healthy lifestyle changes rather than merely selling products. About 90% of OPTAVIA Coaches were customers before becoming Coaches themselves, enhancing the empathetic connection with prospective customers. Coaches utilize digital platforms, word of mouth, and social media to market products, ensuring a scalable approach to customer acquisition and support.

Medifast's offerings consist of:

  1. Independent Coaches: Trained individuals who provide personalized guidance and support to customers, reinforcing the habit-building process.
  2. OPTAVIA Community: A supportive network of like-minded individuals who encourage one another in their health journeys.
  3. Habits of Health® Transformational System: A proprietary system that provides structured steps toward adopting a sustainable healthy lifestyle.
  4. Products & Plans: A selection of clinically validated meal plans and scientifically developed products designed to meet users' nutritional needs.

Programs and Products

Medifast’s products include a diverse array of nutritious meal replacements known as Fuelings, which are designed to be nutrient-dense, portion-controlled, and easy to use. These Fuelings contain essential vitamins, minerals, and probiotics aimed at supporting digestive health. The product line has recently expanded to include OPTAVIA ACTIVE, a range of essential amino acid supplements and protein powders aimed at enhancing nutritional support for active individuals.

In collaboration with LifeMD, OPTAVIA customers gain access to board-certified clinicians and medication options, such as GLP-1s, which support comprehensive obesity treatment plans.

Competitors and Market Position

Medifast operates within a highly competitive weight loss and wellness industry, contending with various players, including traditional diet companies, direct sales organizations, and medically supervised solutions. Key competitors include USANA Health Sciences, WW International (formerly Weight Watchers), and Herbalife Nutrition.

Given the growing recognition of medical weight loss solutions—including GLP-1 medication—Medifast acknowledges both the challenges and opportunities this presents. Their holistic approach blends lifestyle modifications with medical resources, appealing to a broad spectrum of consumers seeking sustainable health solutions.

Recent Initiatives

In response to changing market dynamics, Medifast has begun new initiatives to grow its consumer base and enhance brand visibility since 2023. Significant investments have been directed towards marketing campaigns, upgrading digital interfaces, and expanding into the $30 billion sports nutrition market with the launch of the OPTAVIA ACTIVE product line.

The Company has also entered the realm of medically supported weight loss, integrating clinical guidance with OPTAVIA’s habit-forming approach, providing a comprehensive solution for individuals seeking long-term weight management.

Operational Structure

Medifast operates through several wholly-owned subsidiaries, including Jason Pharmaceuticals and OPTAVIA LLC. The Company maintains a manufacturing facility in Owings Mills, Maryland, which produces about 25% of its total unit sales. Remaining products are manufactured by external partners under stringent proprietary formulas and standards.

Financial Performance

With a solid financial foundation and no debt, Medifast is poised for strategic growth, focusing on capitalizing on its existing resources while redirecting capital from discontinued dividends to enhance marketing and technology initiatives aimed at customer acquisition.

Stock Infos

SectorConsumer Staples
IndustryHousehold and Personal Products
CEODaniel R. Chard

Dividends

Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.